Content about blindness

March 13, 2014

Perrigo announced the launch of methazolamide tablets, the generic version of Neptazane tablets. The product is a component of the rights the company received in connection with its acquisition of a portfolio of ophthalmic products from Fera Pharmaceuticals and its affiliates last year.

DUBLIN — Perrigo announced the launch of methazolamide tablets, the generic version of Neptazane tablets. The product is a component of the rights the company received in connection with its acquisition of a portfolio of ophthalmic products from Fera Pharmaceuticals and its affiliates last year.

May 13, 2013

New Jersey Gov. Chris Christie signed legislation into law that will allow patients using prescription eye drops to get early refills in order to prevent interruptions in therapy.

TRENTON, N.J. — New Jersey Gov. Chris Christie signed legislation into law Monday that will allow patients using prescription eye drops to get early refills in order to prevent interruptions in therapy.

April 22, 2013

The Food and Drug Administration has approved a drug made by Alcon, the drug maker said.

BASEL, Switzerland — The Food and Drug Administration has approved a drug made by Alcon, the drug maker said.

October 18, 2012

The Food and Drug Administration has approved what it called the first drug to treat an eye condition that can interfere with the part of the retina responsible for reading vision.

SILVER SPRING, Md. — The Food and Drug Administration has approved what it called the first drug to treat an eye condition that can interfere with the part of the retina responsible for reading vision.

The agency announced the approval of Jetrea (ocriplasmin), made by Iselin, N.J.-based ThromboGenics. The drug is used to treat symptomatic vitreomacular adhesion.

May 16, 2012

Medication nonadherence costs the U.S. healthcare system about $290 billion per year, according to New England Healthcare Institute. That big and scary number — the kind whose sheer enormity can make one’s eyes glaze over — is now even bigger.


Medication nonadherence costs the U.S. healthcare system about $290 billion per year, according to New England Healthcare Institute. That big and scary number — the kind whose sheer enormity can make one’s eyes glaze over — is now even bigger.


March 7, 2012

EyeScience Labs on Wednesday introduced a new eye vitamin for people with diabetes.

COLUMBUS, Ohio — EyeScience Labs on Wednesday introduced a new eye vitamin for people with diabetes.

February 27, 2012

A division of specialty pharmacy provider The Apothecary Shops has become the exclusive distributor of a drug used in glaucoma surgery, the company said.

PHOENIX — A division of specialty pharmacy provider The Apothecary Shops has become the exclusive distributor of a drug used in glaucoma surgery, the company said.

Apothecary Shop Wholesale has received exclusive distribution rights for Mobius Therapeutics' drug Mitosol (mitomycin), which the Food and Drug Administration approved earlier this month.

October 28, 2011

A volunteer eye health and safety organization has introduced a new program that seeks to educate the public on the potential effects diabetes may have on one's vision.

CHICAGO — A volunteer eye health and safety organization has introduced a new program that seeks to educate the public on the potential effects diabetes may have on one's vision.

August 19, 2011

Americans that suffer from diabetes and/or hypertension are at risk of developing a common type of glaucoma, according to researchers at the University of Michigan Kellogg Eye Center.

NEW YORK — Americans that suffer from diabetes and/or hypertension are at risk of developing a common type of glaucoma, according to researchers at the University of Michigan Kellogg Eye Center.

August 4, 2011

Sam's Club is encouraging customers to protect their eyes by offering free vision screenings at its stores nationwide on Aug. 13.

BENTONVILLE, Ark. — Sam's Club is encouraging customers to protect their eyes by offering free vision screenings at its stores nationwide on Aug. 13.

From 11 a.m. to 3 p.m., both adults and children can receive a vision acuity screening, as well as a quick take-home test called an Amsler Grid, which tests for blurred or missing areas of vision.

June 23, 2011

According to a recent American Eye-Q survey issued earlier this month, only 
32% of Americans understand that the summer sun can do as much damage on the eyes as it does to unprotected skin. Exposure to small amounts of ultraviolet radiation over a period of many years increases the chance of developing cataracts, macular degeneration and eye cancer.

 

February 18, 2011

A drug used to treat high cholesterol, which will lose patent protection and face generic competition starting this year, also may help prevent blindness in people with diabetes, according to a study by researchers at the University of Georgia.

ATHENS, Ga. — A drug used to treat high cholesterol, which will lose patent protection and face generic competition starting this year, also may help prevent blindness in people with diabetes, according to a study by researchers at the University of Georgia.

February 4, 2011

A drug designed to treat an eye condition caused by diabetes may provide a long-term option for patients, according to Alimera Sciences.

ATLANTA — A drug designed to treat an eye condition caused by diabetes may provide a long-term option for patients, according to Alimera Sciences.

Alimera said in two three-year, phase-3 pivotal clinical trials — collectively known as the FAME Study — of Iluvien, which is designed to treat diabetic macular edema, the drug improved visual acuity among patients.

August 31, 2010

The Food and Drug Administration has granted priority review for a diabetic macular edema treatment....

ATLANTA The Food and Drug Administration has granted priority review for a diabetic macular edema treatment.

August 11, 2010

The prevalence of diabetic retinopathy, an eye disease caused by diabetes, has increased among diabetic...

WASHINGTON The prevalence of diabetic retinopathy, an eye disease caused by diabetes, has increased among diabetic adults in the United States, according to a study published in the Journal of the American Medical Association.

June 22, 2010

The Food and Drug Administration has approved a drug made by Genentech for treating a...

June 6, 2010

An investigational treatment for a complication of diabetes that often leads to blindness worked better...

May 2, 2010

Latinos have higher rates of developing visual impairment, blindness, diabetic eye disease and cataracts than...

BETHESDA, Md. Latinos have higher rates of developing visual impairment, blindness, diabetic eye disease and cataracts than non-Hispanic whites, researchers that were part of the "Los Angeles Latino Eye Study" have found. According to a press release issued by the National Eye Institute on Saturday, these are the first estimates of visual impairment and eye disease development in Latinos.

March 2, 2010

More than half the patients taking the low dose of a drug for diabetic macular...

September 30, 2007

PharmaCentra, a marketing firm that provides customized healthcare management programs for the pharmaceutical industry, will...